1. Giovanni S, Antonio S, Barbara I, Salvatoore D. Sirolimus for kaposi's sarcoma in renal-transplant recipients. N Engl J Med. 2005. 352:1317–1323.
2. Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med. 2000. 342:1027–1038.
3. Lebbe C, Euvrard S, Barrou B, Pouteil-Noble C. Sirolimus conversion for patients with posttransplant kaposi's sarcoma. American J Transplantation. 2006. 6:2164–2168.
4. Shepherd FA, Maher E, Cardella C, Cole E, Greig P, Wade JA, et al. Treatment of Kaposi's sarcoma aftre solid organ transplantation. J Clin Oncol. 1997. 15:2371–2377.
5. Brambilla L, Boneschi V, Taglioni M, Ferrucci S. Staging of classic Kaposi's sarcoma: a useful tool for therapeutic choices. Eur J Dermatol. 2003. 13:83–86.
6. Chun HS, Park SC, Choi BS, Yang CW, Moon IS, Go WB. Second and third kidney transplantation in the catholic organ transplantation center. J Korean Soc Transplant. 2006. 20:69–72.
7. Mahendra L, Robert D, Yong-fang K, John A. Risk of malignancy wih long-term immunosuppression in renal transplant recipients. Kidney International. 2004. 66:383–389.
8. Chun EY, Kim SH, Yang UI, Lee MG. Kaposi's sarcoma: a Clinico-Pathological Study of 21 patients. Korean J Dermatol. 2003. 41:1603–1611.
9. Hudnall SD, Rady PL, Trying SK, Fish JC. Hydrocortisone activation of human herpes 8 viral DNA replication and gene expression in vitro. Transplantation. 1999. 67:648–652.
10. Choi WG, Kim JM, Kwon SR, Lee MH, Lee JS, Park W. A case of Kaposi's sarcoma in a Systemic Lupus Erythematosus patient after long term immune suppression. Korean J Rheumatol. 2006. 13:75.